Impact of internal target volume definition for pencil beam scanned proton treatment planning in the presence of respiratory motion variability for lung cancer: A proof of concept.


Journal

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
ISSN: 1879-0887
Titre abrégé: Radiother Oncol
Pays: Ireland
ID NLM: 8407192

Informations de publication

Date de publication:
04 2020
Historique:
received: 13 09 2019
revised: 15 11 2019
accepted: 03 12 2019
pubmed: 3 2 2020
medline: 15 4 2021
entrez: 3 2 2020
Statut: ppublish

Résumé

Motion management is crucial in scanned proton therapy for mobile tumours. Current motion mitigation approaches rely on single 4DCTs before treatment, ignoring respiratory variability. We investigate the consequences of respiratory variations on internal target volumes (ITV) definition and motion mitigation efficacy, and propose a probabilistic ITV based on 4DMRI. Four 4DCT(MRI) datasets, each containing 40 variable cycles of synthetic 4DCTs, were generated by warping single-phase CTs of two lung patients with motion fields extracted from two 4DMRI datasets. Two-field proton treatment plans were optimised on ITVs based on different parts of the 4DCT(MRI)s. 4D dose distributions were calculated by considering variable respiratory patterns. Different probabilistic ITVs were created by incorporating the voxels covered by the CTV in at least 25%, 50%, or 75% (ITV25, ITV50, ITV75) of the cycles, and compared with the conservative ITV encompassing all possible CTV positions. Depending on the selected planning 4DCT, ITV volumes vary up to 20%, resulting in significant variation in CTV coverage for 4D treatments. Target coverage and homogeneity improved with the conservative ITV, but was associated with significantly increased lung dose (~1%). ITV25 and ITV50 led to acceptable plan quality in most cases without lung dose increments. ITV75 best minimised lung dose, but was insufficient to ensure coverage under all motion scenarios. Irregular respiration significantly affects CTV coverage when ITVs are only defined by single 4DCTs. A probabilistic ITV50 provides an adequate compromise between target coverage and lung dose for most motion and patient scenarios investigated.

Identifiants

pubmed: 32007759
pii: S0167-8140(19)33501-7
doi: 10.1016/j.radonc.2019.12.001
pii:
doi:

Substances chimiques

Protons 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

154-161

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Miriam Krieger (M)

Center for Proton Therapy, Paul Scherrer Institute (PSI), Villigen PSI, Switzerland; Department of Physics, ETH Zurich, Switzerland. Electronic address: miriam.krieger@psi.ch.

Alina Giger (A)

Department of Biomedical Engineering, University of Basel, Allschwil, Switzerland; Center for Medical Image Analysis & Navigation, University of Basel, Allschwil, Switzerland.

Rares Salomir (R)

Image Guided Interventions Laboratory (949), Faculty of Medicine, University of Geneva, Switzerland; Radiology Division, University Hospitals of Geneva, Switzerland.

Oliver Bieri (O)

Department of Biomedical Engineering, University of Basel, Allschwil, Switzerland; Department of Radiology, Division of Radiological Physics, University Hospital Basel, Switzerland.

Zarko Celicanin (Z)

Department of Biomedical Engineering, University of Basel, Allschwil, Switzerland; Department of Radiology, Division of Radiological Physics, University Hospital Basel, Switzerland.

Philippe C Cattin (PC)

Department of Biomedical Engineering, University of Basel, Allschwil, Switzerland; Center for Medical Image Analysis & Navigation, University of Basel, Allschwil, Switzerland.

Antony J Lomax (AJ)

Center for Proton Therapy, Paul Scherrer Institute (PSI), Villigen PSI, Switzerland; Department of Physics, ETH Zurich, Switzerland.

Damien C Weber (DC)

Center for Proton Therapy, Paul Scherrer Institute (PSI), Villigen PSI, Switzerland; Department of Radiation Oncology, University Hospital Zurich, Switzerland; Department of Radiation Oncology, Inselspital Bern, Switzerland.

Ye Zhang (Y)

Center for Proton Therapy, Paul Scherrer Institute (PSI), Villigen PSI, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH